PD-L1-positive recurrent and metastatic cervical cancer responsive to first-line Sintilimab with chemotherapy plus Bevacizumab treatment: a case report

Hu Feng,FuJun Yang, Jingjing Mao,Shasha Bi,Shanshan Sun, Hongbo Yang, Haoxing Zhou, Shanshan Song

Authorea (Authorea)（2022）

引用 0|浏览0

暂无评分

摘要

Cervical cancer is the most common malignant tumor of the female reproductive system. Its incidence rate ranks first among that of female malignant tumors in China and has steadily increased in recent years [Juanjuan Jin et al., 2021].

查看译文

关键词

metastatic cervical cancer,cervical cancer,bevacizumab treatment,chemotherapy,first-line

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要